NewsMarketsMarket Round-Up: Aurora Cannabis, Green Thumb Industries, Curaleaf, Emmac,...

Market Round-Up: Aurora Cannabis, Green Thumb Industries, Curaleaf, Emmac, Materia Ventures, et al…


NORTH American cannabis sales hit record levels with Covid-19 lockdown-customers in the both the US and Canada filling their boots.

Bloomberg reports Canadians buying US$181m of cannabis in March, up nearly 20% from February, marking one of the biggest monthly jumps since legalisation in October 2018.

Cannabis plants.

Arcview Market Research and BDS Analytics say US cannabis sales are set to increase by 31% this year to US$16.3bn.

This comes as global cannabis stocks have almost doubled in the last two months, as recorded in New Cannabis Ventures’ Global Cannabis Stock Index.

Pot’s Pandemic Potential?

Booming retail sales have led to improving results from the industry’s main players, and claims by respected scientists on the potential for cannabis in the on-going global pandemic battle have boosted stocks.

A report in the New York Post said a group of Canadian researchers has found medicinal cannabis could block up to 70% of the proteins used by the virus to infect cells.

Edmonton-based Aurora Cannabis generated more than $1bn in US stock trades, sending its stock 69% higher after its Third Quarter results.

These showed it had exceeded revenue expectations, reduced its operating loss, announced divestitures and guided for profits in the next quarter.

Aurora has also joined its fellow leading Canadian Licensed Producers by taking a step into the US CBD industry with the purchase of Reliva for $40m. 

Reliva is one of the best-selling brands in the US; its products can be found in more than 20,000 retail stores across the country.

Multi-State Operators On The UP

Also in the US, many of the Multi-State-Operators are now making enough to wash their face. GrowGeneration, posted quarterly revenues of $33m, representing a 152% improvement from a year ago, whilst anticipating profits for the full year. 

Green Thumb Industries achieved an industry first, generating quarterly revenue in excess of $100m with a 25% adjusted profit margin, reports New Cannabis Ventures. 

Also In the US Investors CapStone Holdings, has taken a $50m stake in Curaleaf. Based in Massachusetts and traded on the Canadian Stock Exchange, Curaleaf serves more than 150,000 medicinal cannabis paints in 17 states, producing a range of pharmaceutical-grade, medical cannabis.

German Purchase For Materia Ventures

Back in Europe, Emmac has become one of the first companies to produce and distribute medical cannabis products. These will be made at its Medalchemy manufacturing site in Spain.

Established UK cannabis cultivator GW Pharmaceuticals says it has sold more of its cannabis derived epilepsy drug Epidiolex in its first quarter.

Materia Ventures – a medical cannabis and wellness company focused on the European market – announced it has acquired Hamburgh-based Cannaktiv, a licensed importer and distributor of medical cannabis products. 

Australian cannabis player MediPharm Labs has secured its first European white-label cannabis supply agreement with Therismos, a subsidiary of Cannaray.

Under the three-year agreement, MediPharm Labs Australia will supply a range of cannabis oil products.

Meanwhile, cannabis powerhouse Israel has eventually given the green light to the export of medical cannabis after months of wrangling, reports Reuters.

Latest news

Poko Innovations, Inc. Receives Validation And Authorization To Sell 44 Items In The UK

POKO Innovations an award-winning UK-based collection of CBD-focused companies that bring innovative, inspiring solutions to the CBD industry through...

Intercure Posts More Record Results But Says It ‘Could Do So Much More’ If It Had More Supply

INTERCURE has released another set of ‘all time record quarterly’ results, seeing both revenues and profits skyrocket year-on-year.  Despite its...

Stenocare Delivers First Product Batch To The Danish Market

STENOCARE delivers the first product batch of their THC Oil to the Danish market. This means that the product is...

Chill Brands Targets Near £4m Capital Raise To Fund Fresh Strategy & £1.3m Domain

CHILL Brands’ shareholders have voted in favour of plans for a new £3.5m fundraise alongside a separate £484,000 open...

Cellular Goods Makes More Major Changes To Board In First Update Since Ingestibles Were Pulled (UPDATED)

Cellular Goods has released its first significant update since announcing that its ingestibles products were not legally allowed to...

European Cannabis Stocks Review: Akanda Dives Over 80% & Celadon Suffers After Reporting Huge Rise In Losses

This week was another difficult week for London Stock Exchange (LSE) listed cannabis companies, with every one of BusinessCann's...

Must read

Intercure Posts More Record Results But Says It ‘Could Do So Much More’ If It Had More Supply

INTERCURE has released another set of ‘all time record...

Chill Brands Targets Near £4m Capital Raise To Fund Fresh Strategy & £1.3m Domain

CHILL Brands’ shareholders have voted in favour of plans...

You might also likeRELATED
Recommended to you